
As we move closer to hashtag#WorldTBDay, it brings into focus how TB screening is evolving on the ground. Where speed and access play a critical role in moving patients from suspicion to diagnosis.
At DeepTek, this journey spans 3 million+ screenings across 800+ sites in 20+ countries—each deployment shaped by the realities of local healthcare systems.
In collaboration with @UNOPS and with local support from Access Spectrum,
DeepTek’s AI-powered lung health screening platform Genki has been deployed across multiple sites including Yangon, Mandalay, and Taunggyi.
These deployments combine fixed and ultra-portable X-ray systems—helping extend screening beyond traditional facilities and closer to communities.
With an incidence rate of 558 per 100,000 population (2023) and nearly 50,000 deaths each year, Myanmar continues to face a significant TB burden—making early and accessible screening critical.
Through connected workflows—from screening and AI-powered triage to confirmatory testing and expert reporting—programs are able to move faster and with greater visibility.
Genki is also WHO-recommended, supporting TB programs globally with scalable, structured screening.
Because ending TB will take more than intent—it will take systems that work on the ground.
Yes, we can end TB — Commit. Invest. Deliver.
Led by UNOPS. Powered by DeepTek.
#worldtbday #aifortb #tbscreening #radiologyai




English
















